期刊文献+

脑胶质瘤中p16蛋白、nm23蛋白及c-erbB-2蛋白的表达及其意义 被引量:3

Expression of p16 protein,nm23 protein and c-erbB-2 protein in the cerebral glioma and implication
原文传递
导出
摘要 目的 探讨p16蛋白、nm2 3蛋白及c erbB 2蛋白在脑胶质瘤发生、发展中的作用。方法 应用免疫组织化学技术检测 60例脑胶质瘤中 p16蛋白、nm2 3蛋白及c erbB 2蛋白的表达。结果 p16蛋白、nm2 3蛋白及c erbB 2蛋白在脑胶质瘤和正常脑组织中的阳性表达率分别为43 .3 %和 90 % (P <0 .0 5 ) ;3 6.7%和 80 % (P <0 .0 5 ) ;41.7%和 0 (P <0 .0 5 )。脑胶质瘤中 p16蛋白及nm2 3蛋白缺失率在死亡组和生存组分别为 73 .7%和 3 1.8% (P <0 .0 5 ) ;84.2 %和 3 6.3 %(P <0 .0 5 ) ;c erbB 2蛋白过度表达率在死亡组和生存组为 68.4%和 2 7.2 % (P <0 .0 5 )。结论 p16蛋白、nm2 3蛋白缺失和c erbB 2蛋白过度表达与脑胶质瘤发生、发展密切相关。 Objective To study the roles of p16 protein,nm23 protein and c erbB 2 protein in the tumorigenesis of the cerebral glioma.Methods The expression of p16 protein,nm23 protein and c erbB 2 protein was detected in 60 cases of cerebral glioma by using immunohistochemical technique.Results The positive expression rate of p16 protein,nm23 protein and c erbB 2 protein in cerebral glioma and normal brain tissues was 43.3% and 90% (P<0.05),36.7% and 80%,41.7% and 0 (P<0.05),respectively.Descended expression rate of p16 protein and nm23 protein in cerebral glioma with death group and survival group was 73.7% and 31.8% (P<0.05),84.2% and 36.3% (P<0.05),respectively.Excessive expression rate of c erbB 2 protein in cerebral glioma with death group and survival group was 68.4% and 27.2% (P<0.05).Conclusion Descended expression of p16 protein,nm23 protein and excessive expression of c erbB 2 protein may have close connection with the tumorigenesis of cerebral glioma.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2002年第1期17-18,共2页 Chinese Journal of Experimental Surgery
关键词 脑肿瘤 胶质瘤 P16蛋白 NM23蛋白 C-ERBB-2蛋白 免疫组织化学技术 预后 Brain neoplasms Glioma p16 protein nm23 protein c erbB 2 protein
  • 相关文献

参考文献1

二级参考文献2

  • 1He J,Cancer Res,1995年,5卷,4833页
  • 2Shi S,J Histochem Cytochem,1991年,39卷,741页

共引文献5

同被引文献23

  • 1林晞,谭德勇,王国丽,孙芝琳.人脑原发性肿瘤中c-erbB-2和c-sis基因的表达研究[J].生物化学杂志,1994,10(4):496-499. 被引量:1
  • 2姚敏,朱建善,刘强,申丽,钱忠心,高金芳,张锦荣.星形细胞瘤中PTEN、p16和p53蛋白表达与预后的关系[J].临床与实验病理学杂志,2005,21(4):407-410. 被引量:1
  • 3毛越苹,段朝晖,尹若菲,曾凡钦,林宝珠.COX-2与BCL-2的表达与皮肤肿瘤的关系[J].中山大学学报(医学科学版),2006,27(2):169-172. 被引量:7
  • 4Scrrano M,Harmon GJ,Beach D,et al.A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4[J].Nature,1993,366(6456):704-707.
  • 5Reed JA,Loganzo F,Shen C J,et al.Loss of expression of suppressor gene in uelanocytic lesions correlates with invasive stages of tumor progression[J].Cancer Res,1995,55(13):2713.
  • 6Kamb A,Gruisn A,Weavrer FJ,et al.A cell cycle regulator potentially involved in genesis of many tumor types[J].Science,1994,264(6):436-447.
  • 7Reed AL,Califano J,Cairns P,et al.High frequency of p16 inactivation in head and neck squamous cell carcinoma[J].Cancer Res,1996,56(5):3630-3633.
  • 8Tam SW,Shay JW,Pagano M.Differential expression and cell cycle regulation of the cyclin-dependent Kinase 4 inhibitor P16 Ink4[J].Cancer Res,1994,54(22):5818-5820.
  • 9PAUL KLEIHUES,CAVENEE W K.WHO Classification of tumors:Pathology and genetics tumors of the nervous system[M].Lyon:IARC Press,2000:10-27.
  • 10RASHEED A,HERNDON J E,STENZEL T T,et al.Molecular markers of prognosis in astrocytic tumors[J].Cancer,2002,94(10):2 688-2697.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部